256 related articles for article (PubMed ID: 30908970)
1. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Khan S; Malla AM; Zafar A; Naseem I
PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
[TBL] [Abstract][Full Text] [Related]
3. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
4. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Khan S; Zafar A; Naseem I
Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
[TBL] [Abstract][Full Text] [Related]
5. Redox cycling of copper by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated modulation of redox scavengers, DNA damage and cell death in diethylnitrosamine induced hepatocellular carcinoma.
Khan S; Zafar A; Naseem I
Bioorg Chem; 2020 Jun; 99():103818. PubMed ID: 32276135
[TBL] [Abstract][Full Text] [Related]
6. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
7. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity.
Zafar A; Singh S; Naseem I
J Nutr Biochem; 2016 Jul; 33():15-27. PubMed ID: 27260464
[TBL] [Abstract][Full Text] [Related]
8. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage.
Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC
Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452
[TBL] [Abstract][Full Text] [Related]
9. Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu
Sharma M; Ganeshpandian M; Majumder M; Tamilarasan A; Sharma M; Mukhopadhyay R; Islam NS; Palaniandavar M
Dalton Trans; 2020 Jun; 49(24):8282-8297. PubMed ID: 32510543
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of a cytotoxic 2-substituted benzimidazole copper(II) complex: DNA damage, antiproliferation and apoptotic induction activity in human cervical cancer cells.
Qiao X; Ma ZY; Shao J; Bao WG; Xu JY; Qiang ZY; Lou JS
Biometals; 2014 Feb; 27(1):155-72. PubMed ID: 24368745
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.
Qi J; Liang S; Gou Y; Zhang Z; Zhou Z; Yang F; Liang H
Eur J Med Chem; 2015; 96():360-8. PubMed ID: 25899339
[TBL] [Abstract][Full Text] [Related]
13. Ferrocene-conjugated L-tryptophan copper(II) complexes of phenanthroline bases showing DNA photocleavage activity and cytotoxicity.
Goswami TK; Chakravarthi BV; Roy M; Karande AA; Chakravarty AR
Inorg Chem; 2011 Sep; 50(17):8452-64. PubMed ID: 21797197
[TBL] [Abstract][Full Text] [Related]
14. High anticancer potency on tumor cells of dehydroabietylamine Schiff-base derivatives and a copper(II) complex.
Zhao F; Wang W; Lu W; Xu L; Yang S; Cai XM; Zhou M; Lei M; Ma M; Xu HJ; Cao F
Eur J Med Chem; 2018 Feb; 146():451-459. PubMed ID: 29407970
[TBL] [Abstract][Full Text] [Related]
15. Doubly chloro bridged dimeric copper(II) complex: magneto-structural correlation and anticancer activity.
Sikdar Y; Modak R; Bose D; Banerjee S; Bieńko D; Zierkiewicz W; Bieńko A; Das Saha K; Goswami S
Dalton Trans; 2015 May; 44(19):8876-88. PubMed ID: 25871579
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
17. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of TPEN variants to improve cancer cells selective killing capacity.
Schaefer-Ramadan S; Barlog M; Roach J; Al-Hashimi M; Bazzi HS; Machaca K
Bioorg Chem; 2019 Jun; 87():366-372. PubMed ID: 30913468
[TBL] [Abstract][Full Text] [Related]
19. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism.
Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY
Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995
[TBL] [Abstract][Full Text] [Related]
20. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
